1 / 74

Update in Hospital Medicine 2009

Update in Hospital Medicine 2009. Kendall M. Rogers, MD Assistant Professor/Chief – Section of Hopital Medicine. Lecture Outline. Trends in Hospital Medicine Literature Review Conclusions and Challenges. Lecture Outline. Trends in Hospital Medicine Growth of the Specialty Health Reform

beate
Télécharger la présentation

Update in Hospital Medicine 2009

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Update in Hospital Medicine2009 Kendall M. Rogers, MD Assistant Professor/Chief – Section of Hopital Medicine

  2. Lecture Outline • Trends in Hospital Medicine • Literature Review • Conclusions and Challenges

  3. Lecture Outline • Trends in Hospital Medicine • Growth of the Specialty • Health Reform • Quality Measures • Literature Review • Conclusions and Challenges

  4. Lecture Outline • Trends in Hospital Medicine • Literature Review • Clinical • Processes of Care • Conclusions and Challenges

  5. Lecture Outline • Trends in Hospital Medicine • Literature Review • Clinical • Inpatient Glycemic Control • H1N1 • Inpatient Resucitation • Clinical Potpourri • Processes of Care • Conclusions and Challenges

  6. Lecture Outline • Trends in Hospital Medicine • Literature Review • Clinical • Processes of Care • Discharge Processes • IT Tools Potpourri • Processes Potpourri • Conclusions and Challenges

  7. Lecture Outline • Trends in Hospital Medicine • Growth of the Specialty • Health Reform • Quality Measures • Literature Review • Clinical • Inpatient Glycemic Control • H1N1 • Inpatient Resucitation • Clinical Potpourri • Processes of Care • Discharge Processes • IT Tools Potpourri • Processes Potpourri • Conclusions and Challenges

  8. Trends In Hospital Medicine

  9. Lecture Outline • Trends in Hospital Medicine • Growth of the Specialty • Health Reform • Quality Measures • Literature Review • Conclusions and Challenges

  10. Growth of Hospital Medicine Specialty • SHM Estimates >28,000 hospitalists currently • Study of Medicare Data • Percentage of physicians in GIM identified as hospitalists increased from 5.9% in 1995 to 19.0% in 2006 • Percentage of all claims for inpatient services by hospitalists increased from 9.1% to 37.1% from 1995 to 2006 • Odds of receiving care from a hospitalist increased by 29.2% per year from 1997 through 2006 Kuo YF, Sharma G, Freeman JL, Goodwin JS. Growth in the care of older patients by hospitalists in the United States. N Engl J Med. 2009 Mar 12;360(11):1102-12.

  11. Health Reform Impact on Hospitalists • Bundled Hospital Payments • HITECH Funding

  12. Health Reform – Bundled Payments • Care Transitions Project – CMS Pilot • One payment to hospitals and providers for an Acute Care Episode • Current project on ortho and cardiac surgeries • Models also could include post hospital care • Implications • Emphasis on preventing re-admissions and quality advances • Hospital/physician power struggles • Would hospitalists predominantly become employees? • Potential for sharing of cost savings • Would specialist take patients back from hospitalists?

  13. Health Reform – HITECH Funding • Part of the ARRA • 37 Billion to incentivize adoption of EHRs (expect 20 billion in savings) • Payments to begin in 2010 • Penalties begin ~2015 • Demonstrate meaningful use of a certified Electronic Health Record (EHR) • ‘Meaningful use’ • ‘Certified EHR’

  14. HITECH Funding Implications • Is current EHR software ready for ‘primetime’ • Do ‘off the shelf’ systems replicate home grown research? • Should the focus be on adoption or development? • Do we have the expertise to implement? • Does this force a customer base for poorly designed software? • For inpatient EHR, hospitalists are and will be ‘go to’ population for implementation

  15. Hold Harmless Clauses/Non-Disclosure • Health IT venders are virtually liability free even when product implicated in adverse events • Learned intermediaries should identify and correct all software faults • Many contracts also include non-disclosure of defects, even to other users of the same system • JC requires hospitals to report safety quality issues • Non-disclosure is unethical in a healthcare setting • These are NEGOTIABLE – take them out of your contracts Ross Koppel, PhD; David Kreda, BA. Health Care Information Technology Vendors' "Hold Harmless" Clause - Implications for Patients and Clinicians. JAMA. 2009;301(12):1276-1278.

  16. Quality Measures • Too many too quick?

  17. From Every Direction • National Quality Forum • Joint Commission • Professional Societies • CMS • Leapfrog • Institute for Healthcare Improvement • Core Measures • Institute of Medicine • National Quality Measure Clearinghouse includes 1849 measures

  18. Quality of Evidence • Antibiotics within 4 hours for CAP – Core Measure • Catheter related UTI – Never Event • Tight Glycemic Control in ICU – Leapfrog • Rapid Response Teams – IHI Initiative • Blood Cultures in CAP – Core Measure • In-Hospital Falls – Never Event • Future Measures: • Delirium • C. Difficile • Staph Aureus Bacteremia

  19. Never Events • Criteria: • Common • Costly • Reasonably can be prevented • “Can be consistentlyand effectively prevented through the application of evidence-basedguidelines”

  20. Preventable Falls as a Measure • Common, Costly, Preventable? • 1 in 5 considered preventable • No study has shown technique that prevent injury from falls Inouye, Brown, Tinetti. Medicare Nonpayment, Hospital Falls, and Unintended Consequences. NEJM V 360:2390-2393. 6/4/2009

  21. Inouye, Brown, Tinetti. Medicare Nonpayment, Hospital Falls, and Unintended Consequences. NEJM V 360:2390-2393. 6/4/2009

  22. Potential Unintended Consequences • Decrease in mobility • Resurgencein the use of physical restraints • Restraints • Do not reduce the risk of fallsor related injuries • Do increasedrates of complications including • Immobility • Functional loss • Delirium and agitation • Pressure sores • Asphyxiation and death • Increase the risk of falling or sustaining an injuryfrom a fall Inouye, Brown, Tinetti. Medicare Nonpayment, Hospital Falls, and Unintended Consequences. NEJM V 360:2390-2393. 6/4/2009

  23. Conclusion on Falls • Using a simple measure to try to fix a complex problem • Could result in harming more patients than it helps • Argued to be cost control in the guise of patient safety

  24. Preventable Catheter Related UTI • Common, Costly, Preventable? • Can be prevented 25 – 75% of the time with multimodal strategies • Current Inaction • 56% of hospitals have no system for monitoring which patients had urinary cathetersplaced • 74% not monitoring how long a catheter hadbeen in place • 9% have catheter removal reminderor stop order Saint, Meddings, et al. Catheter-Associated Urinary Tract Infection and Medicare Rule Changes. Annals of IM 6/16/2009. V 150: 877-884.

  25. Potential Unintended Consequences • More Urinalyses and Urine Cultures, Leading to More Antibiotic Treatment of Asymptomatic Bacteriuria • Increased Opportunity for Fraud • Loss of Important Information for Research and Surveillance • Reduced Access for Some High-Risk Patients • Opportunity Costs Saint, Meddings, et al. Catheter-Associated Urinary Tract Infection and Medicare Rule Changes. Annals of IM 6/16/2009. V 150: 877-884.

  26. Potential Benefits • Increased Focus on Catheter-Associated Urinary Tract Infection • Specific Education for Health Care Workers Focusing on Appropriate and Inappropriate Indications for Urinary Catheterization • Increased Focus on Early Catheter Removal • More Focus on Alternatives to Indwelling Catheterization Saint, Meddings, et al. Catheter-Associated Urinary Tract Infection and Medicare Rule Changes. Annals of IM 6/16/2009. V 150: 877-884.

  27. Recommendations for Hospitals to Address the Centers for Medicare Medicaid Services Rule Changes Regarding Catheter-Associated Urinary Tract Infection Saint, S. et. al. Ann Intern Med 2009;150:877-884

  28. Recommendations to Hospitals for CA UTI Prevention • Develop or adopt existing protocols to ensure that indwelling urinary catheters are used only when medically indicated and that they are inserted and maintained using proper technique • Develop systems to promote removal of urinary catheters when they are no longer indicated • Educate clinicians about the appropriate use and interpretation of urinalysis and urine culture

  29. Conclusion on CA UTIs • Perhaps this will do more good than bad • Must monitor its impact

  30. Quality Measures • Must have sufficient evidence to support beyond single study or single institution • Must monitor all intended and unintended consequences • If not achieving higher quality care, should be dropped

  31. Literature Review

  32. Lecture Outline • Trends in Hospital Medicine • Literature Review • Clinical • Inpatient Glycemic Control • H1N1 • Inpatient Resucitation • Clinical Potpourri • Processes of Care • Conclusions and Challenges

  33. Glycemic Control • Poor glucose control increases mortality • We are still doing a bad job at glycemic control • Some of what we thought is not so

  34. Poor sugar control increases mortality • Poor glucose control was associated with a fourfold increase in mortality and major complications following cardiac surgery • Data: retrospective study of 8,000 adults who underwent cardiac surgery between April 1996 and March 2004 • Major Findings • >50% with moderate (200 to 250 mg/dL) to poor (>250 mg/dL) blood glucose control (BGC) were not previously identified as diabetic • Inadequate BGC was associated with in-hospital mortality (good, 1.8%; moderate, 4.2%; poor, 9.6%; adjusted odds ratio: poor versus good BGC, 3.90) Ascione, Rogers, et al. Inadequate Blood Glucose Control Is Associated With In-Hospital Mortality and Morbidity in Diabetic and Nondiabetic Patients Undergoing Cardiac Surgery. Circulation. 2008;118:113-123

  35. Glycemic Control Poor • Setting: U.S. academic medical centers • Data:1,718 patients discharged from 37 academic medical centers between July 1 and Sept. 30, 2004. • Main Findings: • 84.6% of patients received insulin on day 2 • Recent HgA1C and admission CBG being done varied widely • >70% of patients who received subcutaneous insulin had glucose levels higher than 180 mg/dL on days 1, 2, and 3 • Improved with IV insulin than with subcutaneous insulin, but only 50% of ICU patients had received it on day 1 Boord, Greevy, Braithwaite, et al. Evaluation of hospital glycemic control at US Academic Medical Center. Journal of Hospital Medicine 2009;4:35-44.

  36. Tight Glycemic Control • Background • 2001, Van den Berghe et al reported a reduction in morbidity and mortality with intensive insulin therapy (IIT) in surgical ICU patients • Professional organizations issued guidelines calling for tight control • Hospitals around the world changed their protocols to work toward intensive insulin therapy in ICU patients • Since 2001, further studies have failed to reproduce the same dramatic benefit of IIT N Engl J Med. 2001;345(19):1359-67

  37. Intensive Insulin Therapy • RCT in tertiary-care teaching hospital in Saudi Arabia • Randomized to IIT or conventional insulin therapy (CIT). Protocols to maintain glucose levels of 80 to 110 mg/dL and 180 to 200 mg/dL • The primary endpoint ICU mortality • No statistically significant difference in ICU mortality • (13.5% for IIT vs. 17.1% for CIT; P=0.30). • The adjusted hypoglycemia rate was 6.8 (per 100 treatment days) with IIT and 0.4 with CIT • (P<0.0001) • Patients with hypoglycemia had higher ICU mortality • (23.8% vs. 13.7%, P=0.02) Arabi Y, Dabbagh O, Tamim H, et al. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med. 2008;36(12):3190-3197.

  38. Intensive Insulin Therapy • Bottom line: • Well-designed study failed to show a survival benefit with IIT use in the critical-care setting • Hypoglycemic more common in ITT • Hypoglycemia related to higher mortality Arabi Y, Dabbagh O, Tamim H, et al. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med. 2008;36(12):3190-3197.

  39. Intensive Insulin Therapy • Meta-analysis of 29 RCT with 8,432 patients comparing tight glycemic control (goal <150) to ‘usual care’ • Tight glucose control in critically ill patients had no significant effect on hospital mortality rates • Increased the risk for severe hypoglycemia (<40) • (13.7% risk for tightly controlled patients versus 2.5% for usual care patients) Wiener, Larson,. Benefits and Risks of Tight Glucose Control in Critically Ill Adults: A Meta-analysis. JAMA. 2008;300(8):933-944.

  40. NICE – SUGAR • Open Label RCT, Multinational • 6104 critically ill patients • Intensive infusion (81-108 mg/dL) vs “Conventional” control (144 – 180 mg/dL) • 90 day survival – primary end point NICE-SUGAR Study Investigators, Finfer S, Chittock DR, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009 Mar 26;360(13):1283-97.

  41. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009 Mar 26;360(13):1283-97.

  42. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009 Mar 26;360(13):1283-97.

  43. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009 Mar 26;360(13):1283-97.

  44. NICE - SUGAR ITT vs CGC 90 day mortality 27.5% vs 24.9% Severe hypoglycemia 6.8% vs 0.5% Glucose control (median) 107 vs 141 mg/dL Insulin infusion 97% vs 69% No difference – 30 day mortality, ICU days, hospital days, days of mechanical ventilation, days of renal replacement, organ failures Number needed to harm of 38 NICE-SUGAR Study Investigators, Finfer S, Chittock DR, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009 Mar 26;360(13):1283-97.

  45. What NICE SUGAR does not prove • Tight glycemic control without increased episodes of hypoglycemia worsens or improves mortality

  46. Review what we know • Poor glycemic control is bad • Multi-disciplinary protocol driven care is effective • Current targets should be lower than 180 and prevention of hypoglycemia • Develop and use protocols for subcutaneous insulin (basal bolus) for non-critical ill patients and IV insulin for critically ill patients

  47. At UNM • Paper based basal bolus protocol implemented, education to nursing staff and MDs, multi-disciplinary team • Medicine SAC Floor looking at Patient Day Averages                             July 2008        July 2009 CBG Median            161                144 CBG Mean              176                158 Percent CBG <70      9.6                 5.4 Percent CBG >299   21.6                10.9 >10% Improvement ~50% Reductions

  48. H1N1- Inpatient Implications • Vaccination of healthcare workers • Respiratory Precautions • Healthcare workers • Contingency Plans • Screening/Treatment

More Related